3-Hydroxyphencyclidine (3-HPC), a derivative of phencyclidine (PCP), is increasingly attracting clinical scrutiny due to initial evidence suggesting different physiological actions. Current studies suggest that 3-HPC may display distinct effects on the nervous system, potentially contributing to some of the unexplained reactions linked with PCP exp